Mr Shad Khan
Mr Shad Khan is a highly established consultant Endocrine & General surgeon who sees patients at the New Foscote Hospital, The Manor Hospital, Harley Street Clinic, Churchill Hospital and the John Radcliffe Hospital.
He specialises in parathyroid, thyroid, adrenal and hernia surgery and is the highest volume surgeon in the UK for endocrine surgery – BAETS (Reports – British Association of Endocrine and Thyroid Surgeons (BAETS)).
He was governor of the Oxford University Hospitals Foundation Trust from 2018 to 2022.
Mr Khan completed his surgical training in London before embarking upon a fellowship in the prestigious Oxford Endocrine Unit. Mr Khan works for various charities and performs hernia surgery in Africa and South America.
Mr Shad Khan has published book chapters in endocrine surgery, he has also been published regularly in areas of endocrine surgery. Mr Khan regularly presents and teaches at the European Association of Endocrine Surgeons (ESES) and the British Association of Endocrine & Thyroid Surgeons (BAETS).
He was appointed trustee of the national AMEND society.
- Over 20 years experience
- Clinical Lead for Endocrine Surgery in Oxford University Hospitals
- Former Governor of Oxford University Hospitals
- Day case surgery
- Primary hyperparathyroidism
- Normocalcaemic/ normohormonal hyperparathyroidism
- Scan negative (where scans have not shown any adenoma)
- Redo surgery – where previous operations have failed to cure
- MEN syndrome/ Tertiary hyperparathyroid/ parathyroid cancer
- Suspicious nodules/cancer
- Thyroid nodules
- Overactive thyroid/Graves’ disease
- Multinodular/Retrosternal goitre
- Keyhole surgery via retroperitoneal approach
- Adrenal nodules
- Conn’s syndrome
- Cushing’s syndrome
- Phaeochromocytoma
- Cancer and metastasis
- Specialising in local anaesthetic hernia repair
- Inguinal/groin hernias
- Umbilical/Paraumbilical hernias
- Epigastric hernias
- Incisional hernias
- Keyhole and open operations
Selected publications include:
Puttergill B, Khan S et al. Thyroid lobectomy for low-risk thyroid cancers. Ann R Coll Surg Engl. 2022 Feb
Puttergill B, Khan S et al. Risk of malignancy in thyroid nodules with indeterminate (THY3f) cytology. Ann R Coll Surg Engl. 2022
De Jong MC, Khan S et al. Sarcopenia is Associated with Reduced Survival following Surgery for Adrenocortical Carcinoma. Endocr Res. 2022
HA Iliff, Khan S et al. Management of haematoma after thyroid surgery: systematic review and multidisciplinary consensus guidelines from the Difficult Airway Society, the British Association of Endocrine and Thyroid Surgeons and the British Association of Otorhinolaryngology, Head and Neck Surgery. Anaesthesia. 2022
Aojula N, Khan S et al, Normocalcaemic primary hyperparathyroidism: what is the role of parathyroid surgery? Ther Adv Endocrinol Metab. 2021
De Jong MC, Khan S et al. Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Possible Prognostic Markers for Patients Undergoing Resection of Adrenocortical Carcinoma. World J Surg. 2021
De Jong MC, Khan S et al. Comparative performances of nomograms and conditional survival after resection of adrenocortical cancer. BJS Open. 2021
De Jong MC, Khan S et al. Endocrine Surgery Training in The United Kingdom: a Survey of Higher Surgical Trainees. World J Surg Surgical Res. 2020
Christakis I, Khan S et al. 18Fluorocholine PET/CT scanning with arterial phase-enhanced CT is useful for persistent/recurrent primary hyperparathyroidism: first UK case series results. Ann R Coll Surg Engl. 2019
Chan KKC, Khan S. Unusual presentation of a life-threatening intraperitoneal haemorrhage after elective inguinal hernia repair. BMJ Case Rep. 2018
Khan S et al. A rare case of symptomatic hyperparathyroidism in an elderly patient with dual pathology. AME Case Rep. 2018 May
Haldar A, Khan S et al. Day-case minimally invasive excision of a giant mediastinal parathyroid adenoma. Ann R Coll Surg Engl. 2014
- Royal College of Surgeons
- British Association of Endocrine Surgeons
- European Association of Endocrine Surgeon